• BioXcel (NASDAQ: BTAI) eases liquidity covenant and defers $9M loan payment Stock Titan Mon, 06 Jul 2026 10:03:36 GMT
• Price to sales forward of BioXcel Therapeutics, Inc. – NASDAQ:BTAI TradingView Wed, 01 Jul 2026 22:45:08 GMT
• BTAI Stock Gained 5% Today - What's The Latest On Its Opioid Withdrawal Treatment? Stocktwits Tue, 30 Jun 2026 21:42:10 GMT
• price to sales forward of bioxcel therapeutics, inc. – mun:bx20 TradingView Mon, 29 Jun 2026 19:43:07 GMT
• BioXcel Therapeutics, Inc.(NasdaqCM: BTAI) added to Russell 3000E Growth Benchmark marketscreener.com Mon, 29 Jun 2026 08:16:42 GMT
• BioXcel Therapeutics, Inc.(NasdaqCM:BTAI) added to Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• price to book forward of bioxcel therapeutics, inc. – nasdaq:btai TradingView Sun, 28 Jun 2026 08:54:35 GMT
• price to earnings forward of bioxcel therapeutics, inc. – nasdaq:btai TradingView Sat, 27 Jun 2026 17:07:03 GMT
• enterprise value to revenue forward of bioxcel therapeutics, inc. – nasdaq:btai TradingView Sat, 27 Jun 2026 13:44:51 GMT
• BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yocca Frank Moomoo Sat, 27 Jun 2026 02:58:21 GMT
• bioxcel therapeutics, inc. actuals & estimates (fwb:bx20) TradingView Fri, 26 Jun 2026 17:12:12 GMT
• BioXcel Therapeutics, Inc. Actuals & Estimates (NASDAQ:BTAI) TradingView Fri, 26 Jun 2026 06:31:34 GMT
• bioxcel therapeutics, inc. actuals & estimates (lsx:a40ysr) TradingView Thu, 25 Jun 2026 22:53:11 GMT
• BioXcel Therapeutics Inc. (BTAI) Q1 2026 Earnings: Surprise EPS Beat Drives Stock Rally - Analyst Drop Coverage dars.gov.et Thu, 25 Jun 2026 07:00:00 GMT
• bioxcel therapeutics q1 2026 earnings: eps beat driven by cost controls despite no revenue - share repurchase impact Město Břeclav Tue, 23 Jun 2026 17:34:04 GMT
• btai stock gained 5% today - what's the latest on its opioid withdrawal treatment? Stocktwits Tue, 23 Jun 2026 07:48:41 GMT
• bioxcel therapeutics inc (btai) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• btai stock gained 5% today - what's the latest on its opioid withdrawal treatment? Stocktwits Sat, 20 Jun 2026 20:45:27 GMT
• btai q1 2026 earnings: eps beat amid no revenue; stock edges up - earnings growth analysis dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• btai stock gained 5% today - what's the latest on its opioid withdrawal treatment? Stocktwits Thu, 18 Jun 2026 16:03:39 GMT
• bioxcel therapeutics (nasdaq: btai) officer converts rsus into common stock Stock Titan Thu, 18 Jun 2026 00:34:03 GMT
• bioxcel (btai) ceo exercises 219 rsus and reports major indirect stakes Stock Titan Thu, 18 Jun 2026 00:34:01 GMT
• bioxcel therapeutics (btai) cso converts 35 rsus, now holds 26,210 shares Stock Titan Thu, 18 Jun 2026 00:32:01 GMT
• bioxcel therapeutics inc (btai) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:30:54 GMT
• bioxcel therapeutics inc (btai) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:30:48 GMT
• bioxcel therapeutics inc (btai) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:00:35 GMT
• bioxcel therapeutics inc (btai) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 16:57:32 GMT
• bioxcel therapeutics inc (btai) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 16:56:12 GMT
• bioxcel therapeutics inc (btai) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 16:56:09 GMT
• bioxcel therapeutics inc (btai) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 16:55:06 GMT
• bioxcel therapeutics inc (btai) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 16:54:16 GMT
• BioXcel Therapeutics (NASDAQ: BTAI) officer converts RSUs into Common Stock Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• BioXcel (BTAI) CEO exercises 219 RSUs and reports major indirect stakes Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• BioXcel Therapeutics (BTAI) CSO converts 35 RSUs, now holds 26,210 shares Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Steinhart Richard I Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• bioxcel therapeutics inc (btai) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• bioxcel therapeutics inc (btai) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• bioxcel therapeutics inc (btai) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• bioxcel therapeutics inc (btai) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• btai stock gained 5% today - what's the latest on its opioid withdrawal treatment? Stocktwits Thu, 11 Jun 2026 06:10:05 GMT
• btai stock gained 5% today - what's the latest on its opioid withdrawal treatment? Stocktwits Mon, 08 Jun 2026 19:49:05 GMT
• btai stock gained 5% today - what's the latest on its opioid withdrawal treatment? Stocktwits Sat, 06 Jun 2026 11:37:46 GMT
• attention bioxcel shareholders: kessler topaz meltzer & check, llp reminds shareholders of securities fraud class action lawsuit f... TMX Newsfile Fri, 05 Jun 2026 19:18:30 GMT
• What Makes BioXcel Therapeutics (BTAI) a New Buy Stock Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• bioxcel’s bxcl501 shows efficacy across severity levels in at-home agitation trial The Clinical Trial Vanguard Sun, 31 May 2026 06:54:44 GMT
• BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schi... GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• At-home bipolar and schizophrenia agitation drug cuts symptoms in Phase 3 Stock Titan Thu, 28 May 2026 07:00:00 GMT
• bioxcel presents data on at-home agitation treatment trial Investing.com Thu, 28 May 2026 07:00:00 GMT
• bioxcel therapeutics ceo mehta sells $21,108 in company stock by investing.com Investing.com Nigeria Sun, 24 May 2026 02:54:16 GMT
• bioxcel therapeutics chief legal officer sells $7,111 in stock by investing.com Investing.com Nigeria Sat, 23 May 2026 07:00:00 GMT
• bioxcel therapeutics ceo mehta sells $21,108 in company stock by investing.com Investing.com UK Sat, 23 May 2026 07:00:00 GMT
• bioxcel cfo richard steinhart sells $7,426 of stock by investing.com Investing.com India Sat, 23 May 2026 07:00:00 GMT
• bioxcel therapeutics cso frank yocca sells $7,426 in company stock by investing.com Investing.com India Sat, 23 May 2026 00:22:51 GMT
• BioXcel Therapeutics (BTAI) CSO exercises 17,500 RSUs, sells 6,845 shares for tax payment Stock Titan Fri, 22 May 2026 07:00:00 GMT
• BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock Investing.com Fri, 22 May 2026 07:00:00 GMT
• bioxcel therapeutics (btai) executive sells shares after rsu vesting for taxes Stock Titan Fri, 22 May 2026 07:00:00 GMT
• bioxcel therapeutics chief legal officer sells $7,111 in stock Investing.com Fri, 22 May 2026 07:00:00 GMT
• bioxcel therapeutics ceo mehta sells $21,108 in company stock Investing.com Fri, 22 May 2026 07:00:00 GMT
• bioxcel therapeutics (btai) ceo sells shares to cover rsu tax obligations Stock Titan Fri, 22 May 2026 07:00:00 GMT
• bioxcel (btai) cfo exercises 17,500 rsus and sells 6,845 shares for taxes Stock Titan Fri, 22 May 2026 07:00:00 GMT
• bioxcel therapeutics (btai) rule 144: 6,845 shares from vested rsus Stock Titan Wed, 20 May 2026 07:00:00 GMT
• bioxcel therapeutics (btai) form 144: 19,419 rsus vested, 30.9m shares outstanding Stock Titan Wed, 20 May 2026 07:00:00 GMT
• bioxcel therapeutics (nasdaq: btai) notice to sell 6,560 vested restricted shares Stock Titan Wed, 20 May 2026 07:00:00 GMT
• is bioxcel therapeutics (btai) overvalued after q1 2026? eps not GuruFocus Tue, 19 May 2026 01:28:31 GMT
• bioxcel therapeutics, inc. (btai) reports q1 loss, lags revenue estimates MSN Mon, 18 May 2026 14:37:48 GMT
• is bioxcel therapeutics (btai) overvalued after q1 2026? eps not GuruFocus Mon, 18 May 2026 07:00:00 GMT
• bioxcel therapeutics, inc. (btai) reports q1 loss, lags revenue estimates MSN Sun, 17 May 2026 09:31:31 GMT
• BioXcel Awaits FDA Decision on IGALMI At-Home Label Expansion The Clinical Trial Vanguard Sun, 17 May 2026 07:00:00 GMT
• is bioxcel therapeutics (btai) overvalued after q1 2026 results? GuruFocus Sun, 17 May 2026 06:05:21 GMT
• key facts: btai plans at-home igalmi launch; q4 adjusted loss $0.58 TradingView Sat, 16 May 2026 07:00:00 GMT
• is bioxcel therapeutics (btai) overvalued after q1 2026 results? GuruFocus Sat, 16 May 2026 07:00:00 GMT
• bioxcel therapeutics reports q1 2026 results, fda accepts igalmi snda for at-home use, and explores strategic options Minichart Sat, 16 May 2026 07:00:00 GMT
• bioxcel reports q1 2026 loss; igalmi approval decision due november The Clinical Trial Vanguard Sat, 16 May 2026 06:54:25 GMT
• bioxcel therapeutics (btai) reports first quarter revenue and re GuruFocus Fri, 15 May 2026 18:26:25 GMT
• bioxcel therapeutics reports q1 2026 results, fda accepts igalmi snda for at-home use, and explores strategic options Minichart Fri, 15 May 2026 16:52:00 GMT
• bioxcel therapeutics reports q1 2026 financials, fda update grafa.com Fri, 15 May 2026 15:41:00 GMT
• press release: bioxcel therapeutics provides business update and reports first quarter 2026 financial results Moomoo Fri, 15 May 2026 11:53:41 GMT
• bioxcel therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 11:06:00 GMT
• bioxcel therapeutics (btai) posts q1 2026 loss amid going concern risk Stock Titan Fri, 15 May 2026 11:05:50 GMT
• BioXcel at-home agitation drug gets Nov. 14, 2026 FDA action date Stock Titan Fri, 15 May 2026 07:00:00 GMT
• BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results GlobeNewswire Fri, 15 May 2026 07:00:00 GMT
• BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• BTAI Financials: Income Statement, Balance Sheet & Cash Flow | Bioxcel Therapeutics Inc Stock Titan Fri, 15 May 2026 07:00:00 GMT
• BioXcel weighs sale, other strategic options as New Haven biotech continues losses Hartford Business Journal Fri, 15 May 2026 07:00:00 GMT
• BioXcel Therapeutics 1Q 2026: Revenue $206K, Net income ($12.69M), EPS ($0.54) — 10-Q Summary TradingView Fri, 15 May 2026 07:00:00 GMT
• BioXcel Therapeut reports Q1 2026 net loss $12.7M, revenue $0.2M; FDA sets IGALMI at-home PDUFA Nov 14, 2026 TradingView Fri, 15 May 2026 07:00:00 GMT
• bioxcel therapeutics (nasdaq: btai) posts q1 2026 loss, limited cash and going concern risk Stock Titan Fri, 15 May 2026 07:00:00 GMT
• bioxcel therapeutics inc reports results for the quarter ended december 31 - earnings summary TradingView Fri, 15 May 2026 07:00:00 GMT
• armistice capital reports 7.05% stake in bioxcel (nasdaq: btai) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• number of shareholders of bioxcel therapeutics, inc. – swb:bx20 TradingView Tue, 12 May 2026 11:29:28 GMT
• ai for pharma and biotech market is going to boom | bioxcel therapeutics, benevolentai, nvidia corporation openPR.com Mon, 11 May 2026 11:15:20 GMT
• bioxcel therapeutics, inc. share price today - live nasdaq: btai stock price charts, history Upstox Fri, 08 May 2026 07:00:00 GMT
• javier rodriguez of bioxcel (nasdaq: btai) converts 9,000 rsus to shares Stock Titan Thu, 07 May 2026 07:00:00 GMT
• bioxcel therapeutics (btai) cfo converts 9,000 rsus, now holds 15,645 shares Stock Titan Thu, 07 May 2026 07:00:00 GMT
• bioxcel therapeutics (btai) ceo exercises 18,000 rsus, updates share holdings Stock Titan Thu, 07 May 2026 07:00:00 GMT
• bioxcel therapeutics, inc. (btai) expected to beat earnings estimates: should you buy? MSN Wed, 06 May 2026 23:04:34 GMT
• bioxcel therapeutics, inc. (btai) expected to beat earnings estimates: should you buy? MSN Tue, 05 May 2026 05:02:03 GMT
• BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy? Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
• btai forecast, price target & analyst ratings | bioxcel therapeutics inc (nasdaq:btai) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• btai: igalmi targets a vast at-home market for acute agitation, with launch readiness for 2027 TradingView Thu, 23 Apr 2026 19:43:19 GMT
• btai (bioxcel therapeutics inc.) reports narrower q4 2025 loss than expected, shares gain 7.48 percent on upbeat investor reaction... Xã Thanh Hà Thu, 23 Apr 2026 10:13:02 GMT
• transcript : bioxcel therapeutics, inc. - special call marketscreener.com Thu, 23 Apr 2026 07:00:00 GMT
• btai bioxcel therapeutics inc. gains 7.48 percent after posting narrower than expected q4 2025 eps results. Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 00:43:01 GMT
• btai (bioxcel therapeutics inc.) reports narrower q4 2025 loss than expected, shares gain 7.48 percent on upbeat investor reaction... Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 18:25:48 GMT
• btai bioxcel therapeutics inc. gains 7.48 percent after posting narrower than expected q4 2025 eps results. - investment signal ne... Xã Châu Thành Wed, 22 Apr 2026 16:56:05 GMT
• btai financials: income statement, balance sheet & cash flow | bioxcel therapeutics inc Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• bioxcel therapeutics announces virtual event to discuss commercial launch plan based on market opportunity assessment for igalmi® ... Sahm Sat, 18 Apr 2026 08:47:35 GMT
• bioxcel therapeutics, inc. enters fourth amended and restated registration rights agreement with oaktree investors Minichart Sat, 18 Apr 2026 07:00:00 GMT
• bioxcel therapeutics issues warrants to lenders as part of credit agreement amendment Investing.com Australia Sat, 18 Apr 2026 07:00:00 GMT
• H.C. Wainwright Adjusts BioXcel Therapeutics, Inc. (BTAI) Outlook Following Capital Structure Concerns Yahoo Finance Fri, 17 Apr 2026 07:00:00 GMT
• BioXcel to detail IGALMI launch strategy ahead of FDA decision Investing.com Fri, 17 Apr 2026 07:00:00 GMT
• bioxcel therapeutics announces virtual event to discuss commercial launch plan based on market opportunity assessment for igalmi® ... Yahoo Finance Fri, 17 Apr 2026 07:00:00 GMT
• bioxcel therapeutics issues warrants to lenders as part of credit agreement amendment Investing.com Fri, 17 Apr 2026 07:00:00 GMT
• 86m annual at-home agitation episodes shape bioxcel's igalmi plan Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• bioxcel therapeutics (nasdaq: btai) grants 1,353,729 low-price warrants Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
BioXcel Therapeutics, Inc(NASDAQ:BTAI) 
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic re...
Website: http://www.bioxceltherapeutics.com
Founded: 2017
Full Time Employees: 40
Sector: Healthcare
Industry: Biotechnology